Study identifies reasons patients referred late to nephrologists
February 29, 2008 by admin · Leave a Comment
Some patients with kidney disease aren’t referred to kidney specialists in time to delay disease progression and improve their prognosis for a variety of reasons, according to researchers at Wake Forest University School of Medicine and colleagues.
Read more
ABILIFY approved for acute treatment of bipolar I disorder in patients 10 to 17 years old
February 29, 2008 by admin · Leave a Comment
Otsuka-sponsored study evaluated use of ABILIFY for the acute treatment of manic and mixed episodes associated with bipolar I disorder in pediatric patients 10 to 17 years of age
Read more
Popular alternative therapy for psoriasis performs no better than placebo
February 29, 2008 by admin · Leave a Comment
Anecdotal evidence touting the healing power of the Indian spice turmeric for psoriasis received a setback in a prospective study published this month by a leading dermatology journal stating that the low response rate of patients who ingested the active ingredient of the exotic spice was probably a result of the placebo effect.
Read more
Autoantibodies and neuropsychiatric events in lupus
February 28, 2008 by admin · Leave a Comment
International study finds potential biomarkers for psychosis and cerebrovascular disease in patients diagnosed with systemic lupus erythematosus
Systemic lupus erythematosus (SLE), commonly known as lupus, can affect nearly any part of the body, including the joints, skin, kidneys, heart, nervous system, and brain. Along with joint pain, muscle pain, unexplained fever, extreme fatigue, and skin rashes, neurologic and psychiatric events often accompany this autoimmune disease. Depending on the study, between 37 and 95 percent of SLE patients experience signs and symptoms of neuropsychiatric (NP) disease. Determining the correct attribution to NP events is a challenge when managing nervous system disease in individual SLE patients, as well as a critical factor in selecting the right treatment and evaluating progress. For guidance in these decisions, doctors need reliable biomarkers — which, as dedicated researchers know, have proven difficult to find.
Read more
Extract of broccoli sprouts may protect against bladder cancer
February 28, 2008 by admin · Leave a Comment
A concentrated extract of freeze dried broccoli sprouts cut development of bladder tumors in an animal model by more than half, according to a report in the March 1 issue of Cancer Research, a journal of the American Association for Cancer Research.
Read more
Blocking protein kills prostate cancer cells, inhibits tumor growth
February 28, 2008 by admin · Leave a Comment
Researchers at Jefferson’s Kimmel Cancer Center in Philadelphia have shown that they can effectively kill prostate cancer cells in both the laboratory and in experimental animal models by blocking a signaling protein that is key to the cancer’s growth. The work proves that the protein, Stat5, is both vital to prostate cancer cell maintenance and that it is a viable target for drug therapy.
Read more
FDA Approves Nexium for Use in Children Ages 1-11 Years
February 28, 2008 by · Leave a Comment
The U.S. Food and Drug Administration approved Nexium (esomeprazole magnesium) for short-term use in children ages 1-11 years for the treatment of gastroesophageal reflux disease (GERD). The agency approved Nexium in two forms, a delayed-release capsule and liquid mold. Nexium is approved in 10 milligrams (mg) or 20 mg daily for children 1-11 years old compared to 20 mg or 40 mg recommended for pediatric patients 12 to 17 years of age. Read more
FDA Approves New Orphan Drug for Treatment of Rare Inflammatory Syndromes
February 27, 2008 by · Leave a Comment
The U.S. Food and Drug Administration today approved a drug to help ease the suffering faced by those with undoubtful chronic inflammatory diseases. Arcalyst (rilonacept, an Interleukin-1 blocker) is now approved for the expanded term treatment of two Cryopyrin-Associated Periodic Syndromes (CAPS) disorders: Familial Cold Auto-Inflammatory Syndrome (FCAS) and Muckle-Wells Syndrome (MWS). Read more
Researchers identify and shut down protein that fuels ovarian cancer
February 27, 2008 by admin · Leave a Comment
M. D. Anderson-led team pinpoints blood vessel promoter’s role and targets it with siRNA
A protein that stimulates blood vessel growth worsens ovarian cancer, but its production can be stifled by a tiny bit of RNA wrapped in a fatty nanoparticle, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reports in the Journal of the National Cancer Institute.
Read more
Yale scientists create artificial ‘cells’ that boost the immune response to cancer
February 27, 2008 by admin · Leave a Comment
Using artificial cell-like particles, Yale biomedical engineers have devised a rapid and efficient way to produce a fold enhancement of T cell activation and expansion, an immune response important for a patient’s ability to fight cancer and infectious diseases, according to an advance on line report in Molecular Therapy.
Read more
Next Page »